OverviewChartNewsTraderScreen

Albireo Pharma/  US01345P1066  /

IEX
02/03/2023  21:59:58 Chg. - Volume Bid- Ask- High Low
44.29USD - 39,689
Turnover: 1.76 mill.		 -Bid Size: - -Ask Size: - 44.69 44.02
GlobeNewswire 18/03 Fulcrum Therapeutics Appoints Patrick Horn M.D., Ph.D., as Chief Medical Officer
GlobeNewswire 12/12/2023 Neumora Therapeutics Appoints Jason Duncan as Chief Legal Officer
GlobeNewswire 01/11/2023 MBX Biosciences Announces Appointment of Michelle Graham as Chief Human Resources Officer
GlobeNewswire 23/10/2023 Ipsen updates on E.U. Marketing Authorisation Application for odevixibat in Alagille syndrome
GlobeNewswire 21/08/2023 Amicus Therapeutics Appoints Simon Harford as Chief Financial Officer
GlobeNewswire 29/03/2022 Albireo Completes Enrollment in Pivotal Phase 3 ASSERT Study of BylvayTM (odevixibat) in Alagille Sy...
GlobeNewswire 01/03/2022 Albireo Reports Q4 and Year-End 2021 Financial Results and Business Update
GlobeNewswire 28/02/2022 Noema Pharma Appoints Michael Gutch as Chief Financial Officer
GlobeNewswire 22/02/2022 Albireo to Report Q4 and Year-End 2021 Financial Results on March 1
GlobeNewswire 22/02/2022 NICE Recommends Albireo’s Bylvay® (odevixibat) for All PFIC Types
GlobeNewswire 14/02/2022 Albireo Announces Publication of the PICTURE Study Highlighting the Caregiver Impact of PFIC, a Rare...
GlobeNewswire 05/01/2022 Albireo Increases 2021 Bylvay™ (odevixibat) Sales Guidance
GlobeNewswire 03/01/2022 Liquidia Corporation Announces Chief Executive Officer Transition
GlobeNewswire 16/12/2021 Albireo Announces Positive Topline Data from Phase 1 Study of A3907
GlobeNewswire 13/12/2021 Albireo Presenting New Bylvay™ (odevixibat) Data at NASPGHAN 2021
GlobeNewswire 09/12/2021 Albireo Announces Changes to R&D Organization
GlobeNewswire 02/12/2021 Albireo Expands Leadership with Constantine Chinoporos as Chief Business Officer
GlobeNewswire 12/11/2021 Albireo Announces New Phase 3 Data for Bylvay™ (odevixibat) in PFIC and First Reveal of New Next Gen...
GlobeNewswire 10/11/2021 Albireo to Present at Upcoming Investor Conferences
GlobeNewswire 04/11/2021 Albireo Reports Q3 Financial Results and Business Update
GlobeNewswire 28/10/2021 Albireo to Report Third Quarter 2021 Financial Results on November 4
GlobeNewswire 15/10/2021 Albireo to Showcase New Data at AASLD The Liver Meeting® 2021
GlobeNewswire 12/10/2021 Albireo Announces Exclusive Licensing Agreement with Jadeite Medicines for Bylvay™ (odevixibat) in J...
GlobeNewswire 05/10/2021 Albireo Recognizes PFIC Awareness Day 2021
GlobeNewswire 15/09/2021 Albireo Announces Bylvay® (odevixibat) Now Available in Germany